诺华(NVS)
搜索文档
Novartis(NVS) - 2022 Q2 - Earnings Call Presentation
2022-07-19 16:57
Company overview Financial review 2022 priorities Appendix References 1 Investor Relations │ Q2 2022 Results 台 Q2 2022 Results Investor presentation U NOVARTIS | Reimagining Medicine Company overview Financial review 2022 priorities Appendix References 2 NOVARTIS Q2 RESULTS | JULY 19, 2022 | NOVARTIS INVESTOR PRESENTATION Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified ...
Novartis(NVS) - 2022 Q1 - Earnings Call Presentation
2022-04-26 20:18
Company overview Financial review 2022 priorities Appendix References 1 Investor Relations │ Q1 2022 Results f Q1 2022 Results Investor presentation U NOVARTIS | Reimagining Medicine Company overview Financial review 2022 priorities Appendix References 2 NOVARTIS Q1 RESULTS | APRIL 26, 2022 | NOVARTIS INVESTOR PRESENTATION Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified ...
Novartis (NVS) Investor Presentation - Slideshow
2022-04-14 02:09
Novartis Investor Relations Novartis New Organizational Model Powering our next phase of innovation, growth, and productivity Investor presentation April 04, 2022 Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified by words such as "potential," "expected," "will," "planned," "pipeline," "outlook," or similar expressions, or by express or implied discussions regarding our ne ...
Novartis(NVS) - 2021 Q4 - Earnings Call Presentation
2022-02-04 17:42
Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix û Q4 2021 Results Investor presentation 1 Investor Relations │ Q4 2021 Results U NOVARTIS | Reimagining Medicine 2 NOVARTIS Q4 RESULTS | FEBRUARY 2, 2022 | NOVARTIS INVESTOR PRESENTATION Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform ...
Novartis (NVS) R&D Day - Slideshow
2021-12-09 04:33
| --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------|------------------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | Agenda | Novartis R&D Day | | | | | | | | | Speakers | | | | | | | | | | Novartis Strategy and Growth Story | | | | | | | | | | Cardiovascular and Renal | | | | | | | | | | Immunology, Hepatology & Dermatology | December 2, 2021 | | | | | | | | | Neuroscience | | | | | | | | | | Oncology | | | | | | | | | | | | | | | ...
Novartis(NVS) - 2021 Q3 - Earnings Call Presentation
2021-10-26 22:32
Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References û Q3 2021 Results Investor presentation U NOVARTIS | Reimagining Medicine 1 Investor Relations │ Q3 2021 Results 2 Novartis Q3 Results | October 26, 2021 | Novartis Investor Presentation Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securi ...